128 related articles for article (PubMed ID: 18387765)
1. Where there is no PET/CT.
Kuehl H; Antoch G; Bockisch A; Forsting M
Eur J Radiol; 2008 Aug; 67(2):372. PubMed ID: 18387765
[No Abstract] [Full Text] [Related]
2. Where there is no PET/CT.
Ahmad MN; Zafar AM; Nadeem N
Eur J Radiol; 2009 Jun; 70(3):463-4. PubMed ID: 18387762
[TBL] [Abstract][Full Text] [Related]
3. Comparison of FDG-PET, PET/CT and MRI for follow-up of colorectal liver metastases treated with radiofrequency ablation: initial results.
Kuehl H; Antoch G; Stergar H; Veit-Haibach P; Rosenbaum-Krumme S; Vogt F; Frilling A; Barkhausen J; Bockisch A
Eur J Radiol; 2008 Aug; 67(2):362-371. PubMed ID: 18155866
[TBL] [Abstract][Full Text] [Related]
4. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
[TBL] [Abstract][Full Text] [Related]
5. Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents.
Mainenti PP; Mancini M; Mainolfi C; Camera L; Maurea S; Manchia A; Tanga M; Persico F; Addeo P; D'Antonio D; Speranza A; Bucci L; Persico G; Pace L; Salvatore M
Abdom Imaging; 2010 Oct; 35(5):511-21. PubMed ID: 19562412
[TBL] [Abstract][Full Text] [Related]
6. 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography, computed tomography, and magnetic resonance imaging for the detection of experimental colorectal liver metastases.
de Jong GM; Hendriks T; Bleichrodt RP; Dekker HM; Mus RD; Gotthardt M; Visser EP; Oyen WJ; Boerman OC
Mol Imaging; 2012 Apr; 11(2):148-54. PubMed ID: 22469242
[TBL] [Abstract][Full Text] [Related]
7. Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results.
Veit P; Antoch G; Stergar H; Bockisch A; Forsting M; Kuehl H
Eur Radiol; 2006 Jan; 16(1):80-7. PubMed ID: 15868122
[TBL] [Abstract][Full Text] [Related]
8. Impact of whole-body imaging on treatment decision to radio-frequency ablation in patients with malignant liver tumors: comparison of [18F]fluorodeoxyglucose-PET/computed tomography, PET and computed tomography.
Kuehl H; Rosenbaum-Krumme S; Veit-Haibach P; Stergar H; Forsting M; Bockisch A; Antoch G
Nucl Med Commun; 2008 Jul; 29(7):599-606. PubMed ID: 18528181
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation.
Rappeport ED; Loft A; Berthelsen AK; von der Recke P; Larsen PN; Mogensen AM; Wettergren A; Rasmussen A; Hillingsoe J; Kirkegaard P; Thomsen C
Acta Radiol; 2007 May; 48(4):369-78. PubMed ID: 17453514
[TBL] [Abstract][Full Text] [Related]
10. Can PET-CT with FDG replace contrast enhanced CT for imaging of liver metastases?
Strauss LG; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):1902-5. PubMed ID: 17938920
[No Abstract] [Full Text] [Related]
11. PET imaging for evaluation of metastatic colorectal cancer of the liver.
Erturk SM; Ichikawa T; Fujii H; Yasuda S; Ros PR
Eur J Radiol; 2006 May; 58(2):229-35. PubMed ID: 16457980
[TBL] [Abstract][Full Text] [Related]
12. Image-guided Treatment in the Hepatobiliary System: Role of Imaging in Treatment Planning and Posttreatment Evaluation.
Bajpai S; Kambadakone A; Guimaraes AR; Arellano RS; Gervais DA; Sahani D
Radiographics; 2015; 35(5):1393-418. PubMed ID: 26252365
[TBL] [Abstract][Full Text] [Related]
13. The use of PET-MRI in the follow-up after radiofrequency- and microwave ablation of colorectal liver metastases.
Nielsen K; Scheffer HJ; Pieters IC; van Tilborg AA; van Waesberghe JH; Oprea-Lager DE; Meijerink MR; Kazemier G; Hoekstra OS; Schreurs HW; Sietses C; Meijer S; Comans EF; van den Tol PM
BMC Med Imaging; 2014 Aug; 14():27. PubMed ID: 25103913
[TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin-assisted hydrodissection of the gallbladder fossa during FDG PET/CT-guided liver ablation.
Tewari SO; Petre EN; Osborne J; Sofocleous CT
Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1704-1706. PubMed ID: 23839009
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
[TBL] [Abstract][Full Text] [Related]
16. Y90 radioembolization of colorectal cancer liver metastases: response assessment by contrast-enhanced computed tomography with or without PET-CT guidance.
Vouche M; Salem R; Miller FH; Lemort M; Vanderlinden B; De Becker D; Hendlisz A; Flamen P
Clin Imaging; 2015; 39(3):454-62. PubMed ID: 25724225
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of early 18F-FDG PET to evaluate the effectiveness of radiofrequency ablation of liver metastases.
Khandani AH; Calvo BF; O'Neil BH; Jorgenson J; Mauro MA
AJR Am J Roentgenol; 2007 Nov; 189(5):1199-202. PubMed ID: 17954661
[TBL] [Abstract][Full Text] [Related]
18. Invited editorial: Response to therapy assessment of colorectal liver metastasis.
Maffione AM; Rampin L; Blickman JG; Rubello D
Eur J Radiol; 2013 Jun; 82(6):903-4. PubMed ID: 23518147
[No Abstract] [Full Text] [Related]
19. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?
Selzner M; Hany TF; Wildbrett P; McCormack L; Kadry Z; Clavien PA
Ann Surg; 2004 Dec; 240(6):1027-34; discussion 1035-6. PubMed ID: 15570208
[TBL] [Abstract][Full Text] [Related]
20. Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer.
Laurens ST; Oyen WJ
PET Clin; 2015 Jul; 10(3):345-60. PubMed ID: 26099671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
